Skip to main content

Atle Fund Management AB

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1381843 STOCKHOLM, V7

Position in VRTX

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$9,502,941
-$760,334 QoQ
Shares Held
19,131
-16.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
2.56%
of 13F equity value
Holder Rank
#379
of 1,735 holders
Holding Since
Mar 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Atle Fund Management AB holds $141,162,145 across 21 Biotechnology names. VRTX ranks #5 (6.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
19,131 $9,502,941

All Filings in VRTX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,502,941 19,131
2026-03-31 $10,263,275 22,984
2025-12-31 $10,420,026 22,984
2025-09-30 $738,675 17,766
2025-06-30 $10,830,825 24,328
2025-03-31 $11,057,774 22,808
2024-12-31 $8,962,893 22,257
2024-09-30 $7,903,104 16,993
2024-06-30 $7,075,328 15,095
2024-03-31 $4,721,422 11,295
2023-12-31 $3,714,905 9,130
2022-12-31 $62,376 216
2021-06-30 $10,484,760 52,000
2021-03-31 $7,521,150 35,000